Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Systemic Variables in the Saliva of Children Undergoing Liver Transplantation

The recruitment status of this study is unknown because the information has not been verified recently.
Verified December 2007 by Hadassah Medical Organization.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT01307163
First received: January 10, 2008
Last updated: March 1, 2011
Last verified: December 2007
  Purpose

Saliva is used nowadays as a significant diagnostic tool due to the latest technological developments. The research compares two experimental groups; children after liver transplantation and a control group.

Our objective is to identify from all the parameters that are evaluated, the ones that differ between the two groups. If such parameters will be found and differ statistically, it will be possible to create a non invasive medical examination protocol, which will probably be much more complaint, and being so would help locate individuals in risk groups with the tendency to develop an end-organ liver disease.


Condition
Liver Transplant

Study Type: Observational
Study Design: Observational Model: Cohort
Official Title: Systemic Variables in the Saliva of Children Undergoing Liver Transplantation

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Biospecimen Retention:   Samples Without DNA

saliva


Estimated Enrollment: 60
Study Start Date: January 2008
Estimated Study Completion Date: December 2008
Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   2 Years to 16 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

In this prospective study 60 subjects will be examined. Children and adolescents from Schnaidder's hospital for children after a successful liver transplantation will be characterized as the study group. As a control group, 32 healthy examinees in the same age group will be selected from the dental pediatric department at Hadassah hospital, Ein karem, Jerusalem

Criteria

Inclusion Criteria:

  • Children after a successful liver transplantation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01307163

Locations
Israel
Hadassah Medical Organization IRB Not yet recruiting
Jerusalem, Israel, 12000
Contact: Esti Davidovich, DMD       dr-st@012.net.il   
Sponsors and Collaborators
Hadassah Medical Organization
  More Information

No publications provided

Responsible Party: DR. Esti Davidovich, Hadassah Medical Organization
ClinicalTrials.gov Identifier: NCT01307163     History of Changes
Other Study ID Numbers: ran19-HMO-CTIL, esti19
Study First Received: January 10, 2008
Last Updated: March 1, 2011
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Hadassah Medical Organization:
saliva
liver transplantation
children
In this prospective study 60 subjects will be examined
children and adolescents
after a successful liver transplantation
informed consent forms signed be the examinees parents

ClinicalTrials.gov processed this record on November 27, 2014